APHQF - Aphria Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
11.57
0.00 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close11.57
Open12.21
Bid0.00 x 0
Ask0.00 x 0
Day's Range11.57 - 11.57
52 Week Range6.59 - 19.87
Volume1,873,759
Avg. Volume2,360,618
Market Cap2.89B
Beta (3Y Monthly)4.05
PE Ratio (TTM)85.70
EPS (TTM)0.14
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • InvestorPlace11 hours ago

    29 Marijuana Stocks to Buy as the Future Turns Green

    With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.

  • Tilray Rose 13% Today after Falling for Six Days
    Market Realist12 hours ago

    Tilray Rose 13% Today after Falling for Six Days

    After the news of Tilray’s intention to purchase hemp-derived CBD isolate from LiveWell Canada came out, Tilray stock rose more than 13% on December 18. At 9:50 AM EST on December 18, Tilray stock posted a day high of $74.69—up 13.4% from the previous session’s closing price. Last week, Tilray announced its investments in ROSE LifeScience.

  • TheStreet.com8 days ago

    How to Invest in Cannabis - In Its Many Forms

    California legalized recreational marijuana at the very beginning of 2018. The cannabis industry grows very quickly. Both directly and indirectly, there are a number of ways you can turn cannabis into one of the more intriguing investments in your portfolio.

  • What Citron Research Has to Say about Aphria
    Market Realist9 days ago

    What Citron Research Has to Say about Aphria

    Last week was a brutal week for Aphria (APHA) (APHQF). Aphria’s troubles began last Monday when Gabriel Grego of Quintessential Capital Management called the stock “worthless” and explained in detail why he believes the company destroyed shareholder value. Aphria fought back and appointed a special committee that consists of independent directors who will be tasked with reviewing the allegations.

  • Why Aphria Tanked Over 11% Today
    Market Realist11 days ago

    Why Aphria Tanked Over 11% Today

    Today, Aphria (APHA)(APHQF) resumed a sharp sell-off in its stock from early this month after surging a whopping 51% yesterday. Now, let’s find out what could be driving Aphria stock down today. Grego alleged that “Aphria had diverted funds into inflated investments held by insiders.” Since then, these allegations have taken a massive toll on investors’ confidence.

  • Short Seller Not Backing Down on Aphria
    Market Realist11 days ago

    Short Seller Not Backing Down on Aphria

    On December 6, Aphria’s (APHQF) short seller, Hindenburg Research, released its Part 2 on what it found to be further malice in the company’s acquisition efforts. According to the research, this acquisition showed a 5 million Canadian dollar gain to Aphria’s insider in a matter of six days. Further, the report pointed out that Aphria’s CEO, Vic Neufeld, was also a part of the “discount round” in which Aphria purchased companies at overpriced valuations. Even more damning was the short seller’s observation that the SEC had alleged that the individuals that Aphria purchased companies from were involved in pump and dump schemes.

  • Aphria’s Announcement of Special Committee Pauses Sell-Off
    Market Realist12 days ago

    Aphria’s Announcement of Special Committee Pauses Sell-Off

    Aprhia (APHQF) recovered by nearly 50% on December 6 due to its further commitment to relieve investors’ fears related to its Latin America business. The company appointed a special committee that consists of independent directors who will be tasked with reviewing the legitimacy of the company’s acquisitions in Latin America. The above chart shows that Aphria (APHQF) is among the top ten holdings in the Horizons Marijuana Life Sciences ETF (HMMJ).

  • Aphria Claws Back after Brutal Sell-Off
    Market Realist12 days ago

    Aphria Claws Back after Brutal Sell-Off

    On December 6, Aphria (APHQF) (APHA) clawed back after a brutal sell-off in which the company lost nearly half of its value in just the first three days of this week. In contrast, Aurora Cannabis (ACBFF), Tilray (TLRY), and Cronos Group (CRON) were all in the negative territory. At the heart of Aphria’s downfall was a short seller’s allegation that acquisitions in Latin American were made at inflated prices.

  • Eight Capital Cut Aphria’s Target Price
    Market Realist13 days ago

    Eight Capital Cut Aphria’s Target Price

    Aphria (APHQF) (APHA) has been reeling due to scandalous allegations regarding the company’s business activities. There doesn’t seem to be a bottom for the stock. Aphria stock lost nearly 25% on December 5. The stock has lost 42% in the three trading days in December.

  • Analysts Downgrade Aphria amid Possible Violations
    Market Realist13 days ago

    Analysts Downgrade Aphria amid Possible Violations

    On December 4, the NYSE halted Aphria (APHA) (APHQF) in the pre-market session. The trading resumed after Aphria clarified allegations about its Latin America business.

  • Law Firms Investigate Aphria for Potential Violations
    Market Realist14 days ago

    Law Firms Investigate Aphria for Potential Violations

    Due to Aphria’s (APHA) (APHQF) broad sell-off, several investors lost their investments. The investments might not be recovered if the claims against the company are true. As a result, Johnson Fistel LLP, a law firm, announced that it’s investigating Aphria for possibly violating the securities law. In a statement, the law firm sought information related to violations from the public and past employees. Johnson Fistel LLP also encouraged investors that suffered losses to contact the firm.

  • Aphria Continued to Fall despite the Company’s Defense
    Market Realist14 days ago

    Aphria Continued to Fall despite the Company’s Defense

    On December 4, Aphria (APHA) (APHQF) continued to fall. There were negative remarks that the company diverted investors’ funds to companies in Latin America that were linked to insiders at inflated values. Aphria lost almost 21.2% on December 4. The stock fell to 5.99 Canadian dollars from 6.6 Canadian dollars.

  • Aphria Had One of Its Worst Days on December 3
    Market Realist15 days ago

    Aphria Had One of Its Worst Days on December 3

    On December 3, Aphria (APHQF) (APHA) had one of its worst days after falling nearly 28% in the Canadian exchange to 7.6 Canadian dollars from 10.51 Canadian dollars. Aphria fell due to a scathing remark made by a bearish investor, Gabrial Grego of Quintessential Capital Management. The news comes right after Aphria had one of its worst months in November. Aphria stock fell nearly 30%, while other stocks in the cannabis industry (HMMJ) experienced a relatively better month.

  • Investopedia15 days ago

    10 Canadian Marijuana Stocks for Your Portfolio

    With the United States trending towards legalization, these penny stocks offer direct exposure and could help you get a piece of the pot.

  • Why Did Aphria Stock Fall 30% in November?
    Market Realist16 days ago

    Why Did Aphria Stock Fall 30% in November?

    Aphria (APHQF) stock fell nearly 30.6% in November. The stock closed at 10.5 Canadian dollars on November 30, which declined from 15.2 Canadian dollars at the beginning of the month.

  • Canopy Growth: Next Generation of Cannabis Products
    Market Realist19 days ago

    Canopy Growth: Next Generation of Cannabis Products

    With smoking restrictions in public and the workplace, cannabis in the form of a dried flower might not be the most preferred way to enjoy cannabis. Canopy Growth (WEED) refers to the process of converting the dried flower to other forms as “value-addition.” The above chart shows the possibilities for value-addition. Canopy Growth thinks that it’s important to move into value-added products like soft gels and pre-rolled products.

  • Aurora Advances in Czech Republic with Medical Cannabis Shipments
    Market Realist21 days ago

    Aurora Advances in Czech Republic with Medical Cannabis Shipments

    On November 27, Aurora Cannabis (ACB) (ACBFF) announced that it completed its first shipment to the Czech Republic after it was able to secure an export permit to ship medical cannabis to the country. The below chart shows Aurora Cannabis’s market reach around the world. The medical cannabis was shipped to Czech Medical Herbs, which is a wholesaler of pharmaceutical products in the country.

  • Canopy Growth Completes EBBU Acquisition
    Market Realist22 days ago

    Canopy Growth Completes EBBU Acquisition

    Pursuant to its efforts towards the development of intellectual property (or IP) related to cannabis products, Canopy Growth (WEED)(CGC) announced yesterday that it completed the previously announced acquisition of EBBU. Canopy Growth stated that the acquisition will help it make advancements in its THC and hemp-based genetic breeding of cannabis as well as drinks infused with cannabis.

  • Cannabis Stocks: Valuations Fell from Last Month’s Peak
    Market Realist28 days ago

    Cannabis Stocks: Valuations Fell from Last Month’s Peak

    Previously in this series, we discussed cannabis stocks’ aggregate EV-to-sales multiple. The valuation multiple fell month-over-month from the peak of 13.0x to 5.1x as of November 20. The multiple fell because most cannabis companies (MJ) experienced a decline in their enterprise value due to the major sell-off that occurred in November.

  • What Analysts Think about Aphria in November
    Market Realist28 days ago

    What Analysts Think about Aphria in November

    Aphria (APHQF) has had one of the weakest months compared to other cannabis companies (HMMJ) such as Canopy Growth (WEED), Supreme Cannabis (SPRWF), and HEXO (HEXO). In this month alone, the stock has declined by nearly 21.4%. Let’s look at what analysts think.

  • What Analysts Recommend for Cronos Group in November
    Market Realist29 days ago

    What Analysts Recommend for Cronos Group in November

    On November 13, Cronos Group (CRON) reported its quarterly results. It posted sales of 3.7 million Canadian dollars, which beat analysts’ consensus estimate of 3.6 million Canadian dollars, and the margins also remained healthy. However, the company’s bottom line struggled. Read more at Key Updates on Cronos Group’s Third-Quarter Earnings. Let’s look at what analysts recommend for the stock.

  • November Update: How Analysts Rate Cannabis Stocks after Earnings
    Market Realist29 days ago

    November Update: How Analysts Rate Cannabis Stocks after Earnings

    While the overall markets were filled with negative sentiments, the earnings season for cannabis stocks dampened the excitement in the sector. Most of the cannabis companies missed consensus estimates. In the above chart, you can see some of the big cannabis names (HMMJ) that saw an impressive run-up in October 2018 as marijuana became legal in Canada.

  • Key Takeaways from Canopy Growth’s Second-Quarter Earnings
    Market Realistlast month

    Key Takeaways from Canopy Growth’s Second-Quarter Earnings

    On November 14, Canopy Growth (WEED) (CGC) reported its second-quarter earnings, which largely disappointed the market. As a result, the stock took a beating with an 11% decline to $34.3. The company reported revenues of 23.3 million Canadian dollars, which missed analysts’ estimate of 61.7 million Canadian dollars.

  • Does Aurora Think Recreational Cannabis Sales Lived Up to Hype?
    Market Realistlast month

    Does Aurora Think Recreational Cannabis Sales Lived Up to Hype?

    One of the most anticipated aspects of Aurora Cannabis’s (ACB) (ACBFF) earnings results was an update on the recreational cannabis (HMMJ) market demand. In its press release, Aurora Cannabis stated that the company had a “strong performance” in the recreational cannabis segment during the quarter, which ended in September 2018. During the first quarter, the company stated that its brands accounted for nearly 30% of the total cannabis supplied through the OCS (Ontario Cannabis Store) with San Rafael being Aurora’s top brand sold in Ontario.

  • Most Cannabis Companies Expected to Report Losses for the Quarter
    Market Realistlast month

    Most Cannabis Companies Expected to Report Losses for the Quarter

    Aurora Cannabis (ACB) is estimated to report a loss per share of 0.07 Canadian dollars, which would be lower than the profit per share of 0.01 Canadian dollars in the corresponding quarter of 2017. Cronos (CRON) is expected to report a loss per share of 0.02 Canadian dollars, which is flat compared to the corresponding quarter a year ago. Tilray (TLRY) is expected to report a loss per share of 0.13 Canadian dollars for the quarter.